Phase III Results Prime Dupixent as First Potential Biologic Approval for COPD | BioSpace ift.tt/KCPpX5n

Extending Botulinum Treatments ift.tt/q6zXlud

Thermo Fisher gets FDA clearance for first blood test of severe preeclampsia risk ift.tt/Qb3xc6S

Beta Bionics wins FDA nod to challenge Medtronic for automated insulin pump market ift.tt/7fM1DEi

China’s NMPA accepts IND for SinoMab BioScience’s SM17 ift.tt/Bh8F4X3

ReNAgade debuts with $300M and an ‘all-in-one’ system for delivering RNA drugs ift.tt/HAREgN2

Hepion Claims Phase II NASH Victory Following Intercept’s Adcomm Defeat | BioSpace ift.tt/cwoXkA1

Seelos Therapeutics to Participate in Two Upcoming Healthcare Conferences | BioSpace ift.tt/e8jlWtM

Milestone Pharmaceuticals Announces Presentation of Data from Analysis of Etripamil Nasal Spray in Patients Experiencing Atrial Fibrillation with Rapid Ventricular Rate ift.tt/QbM3FPv

2022 Prescription Trends ift.tt/e4rT0PS

Centessa Pharmaceuticals Receives Fast Track Designation from the U.S. FDA for SerpinPC for Hemophilia B | BioSpace ift.tt/r7aenou

Krystal Biotech Announces $160 Million Private Placement Equity Financing | BioSpace ift.tt/JB8ywgK

Pfizer’s maternal RSV vaccine candidate backed by FDA advisory committee ift.tt/TFMe1x8

Researchers asking for AI regulations, in this week's R&D Power Index - Research & Development World ift.tt/9zDcUIh

FDA Approves First Nasal Nalmefene Spray for Opioid Overdose.   | BioSpace ift.tt/NLMXa4z

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Award for Novel Cancer Immunotherapy Treatment | BioSpace ift.tt/Y2pHc9x

NHS to introduce world-first genetic blood-matching test for transfusion treatments ift.tt/6NZK39E

How does a 200 year-old company continue to innovate? We spoke to Bormioli Pharma about their continuous #openinnovation process in the latest episode of PharmaSource podcast. Listed here or wherever you get your pods: open.spotify.com/show/1XQ07XUDc…

"Most Chief Data Officers focus on the Data Lake. But it gets polluted over time and quickly becomes a data swamp as there’s still trash coming in every day through the river." Johannes Galatsanos Novartis Listen to the latest episode: linkedin.com/feed/update/ur…

Staying a step ahead of the drug counterfeiters: how pharma procurement teams can protect #supplychain integrity w/ . The latest podcast is out now pharmasource.global/content/podcas…